US Patent 10906879 Crystalline substituted pyrazines as PGI2 receptor agonists
Patent 10906879 was granted and assigned to Nippon Shinyaku on February, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 27, 2018
0
Date of Patent
February 2, 2021
0
Patent Applicant
Patent Application Number
16650390
0
Patent Inventor Names
Toshio Fujiwara
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10906879 Crystalline substituted pyrazines as PGI2 receptor agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.